#APIs
Explore articles tagged with APIs
The US Drug Pricing Shock: A Mandate for Recalibration, Not Reaction
HRV Pharma's CEO Hari Kiran Chereddi outlines strategic recalibration approach to US drug pricing policies, emphasizing global diversification and value-based transformation over reactive market responses.
Express Pharma June 2025 Feature : The New Rules of Pharma
HRV Pharma is redefining pharmaceutical manufacturing through distributed orchestration, compliance-driven models, and technology-first strategies to build resilient, globally connected supply chains for the future.
Life Sciences Sector Maximizes Advanced Technology Adoption
HRV Pharma's leadership shares insights on National Technology Day 2025, highlighting how AI, machine learning, and digital technologies are revolutionizing healthcare delivery and pharmaceutical innovation
Market Momentum: Dynamic Drivers of Pharmaceutical Growth
Comprehensive analysis of key forces driving pharmaceutical industry transformation, from biotech advances and AI-powered drug discovery to emerging markets and virtual pharma models reshaping global healthcare.
Pharma 4.0: Smart Manufacturing Redefining Generic Drug Production
Explore how AI, automation, and real-time analytics are transforming generic drug production through smart manufacturing and continuous processes.
Green Pharma 2.0: AI and Digital Twins Revolutionizing Indian Pharmaceutical Manufacturing
HRV pharma's Hari Kiran Chereddi discusses AI, digital twins, and sustainable molecule design transforming Indian pharmaceutical manufacturing.
India's API Industry at a Key Juncture: Navigating Global Supply Chain Dynamics
HRV Pharma's Sreenivas Varma discusses India's API industry transformation, PLI schemes, and the shift towards high-value pharmaceutical manufacturing.
HRV Pharma Facilitates Historic First Shipment of Indian Anti-Diabetic Drugs to Argentina
In a significant milestone for India-Argentina healthcare cooperation, HRV Pharma has successfully delivered the first consignment of USFDA-qualified Metformin to Mendoza province, achieving estimated savings of 45-50% for patients.
Indian Pharma's Strategic US Expansion: Insights from Hari Kiran Chereddi
Hari Kiran Chereddi shares strategic insights on Indian pharma’s US expansion via acquisitions, regulatory agility, and supply chain resilience in a competitive market.
HRV Pharma Showcases Virtual Manufacturing Innovation at Industry Conference
CEO Hari Kiran Chereddi highlights HRV’s virtual manufacturing model, blending AI and blockchain to redefine pharma production and global market access.
HRV Pharma Eyes Strategic Expansion into Sri Lankan Pharmaceutical Market
HRV Pharma has announced its strategic interest in expanding operations into Sri Lanka, positioning the island nation as a key growth market in the company's South Asian expansion strategy.
Hari Kiran Chereddi Featured in Exclusive CPhI Milan Interview
HRV’s CEO discusses virtual pharma models and navigating complex global markets in a CPhI Milan interview, emphasizing innovation and regulatory mastery.
HRV Pharma Honored with Dual Leadership Awards for Excellence in India and Middle East Markets
HRV Pharma has been honored with two prestigious leadership awards, recognizing the company as a leading pharmaceutical enterprise in both India and the Middle East markets